Abiopharma

News list

Director SACHIN J. MEHRA 🟡 adjusted position in 0 shares (1 derivative) of Salesforce, Inc. (CRM) Transaction Date: Aug 22, 2026 | Filing ID: 000178

Full text

News bot Aug. 25, 2026, 12:08 a.m.
🔍 SACHIN J. MEHRA (Director)

Company: Salesforce, Inc. (CRM)

Report Date: 2026-08-22
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 441
- Total shares sold: 441
Detailed Transactions and Holdings:
- Acquired 441 shares of Common Stock (Direct)
  Date: 2026-08-22 | Code: M | equity_swap_involved: 0 | shares_owned_after: 5,406.00 | transaction_form_type: 4
- Sold 441 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-22 | Code: M | Expires: 2026-11-22 | Exercise: 2026-02-22 | equity_swap_involved: 0 | shares_owned_after: 441.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Restricted Stock Units convert to shares of common stock on a one-for-one basis.
- F2: These restricted stock units vest as to 25% of the original grant on each of February 22, 2026, May 22, 2026, August 22, 2026, and November 22, 2026.